Yair Gazitt
Cancer Therapy & Research Center
The University of Texas Health Science Center
San Antonio
TX 78284
USA
Name/email consistency: high
- Targeted therapy of human osteosarcoma with 17AAG or rapamycin: characterization of induced apoptosis and inhibition of mTOR and Akt/MAPK/Wnt pathways. Gazitt, Y., Kolaparthi, V., Moncada, K., Thomas, C., Freeman, J. Int. J. Oncol. (2009)
- Improved mobilization of peripheral blood CD34+ cells and dendritic cells by AMD3100 plus granulocyte-colony-stimulating factor in non-Hodgkin's lymphoma patients. Gazitt, Y., Freytes, C.O., Akay, C., Badel, K., Calandra, G. Stem Cells Dev. (2007)
- No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF. Gazitt, Y., Akay, C., Thomas, C. Stem Cells Dev. (2006)
- A phase II trial with gemcitabine and paclitaxel for the treatment of refractory and relapsed multiple myeloma patients. Gazitt, Y., Shaughnessy, P., Rothenberg, M.L. Oncol. Rep. (2006)
- Arsenic trioxide: an anti cancer missile with multiple warheads. Gazitt, Y., Akay, C. Hematology (2005)
- Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4. Gazitt, Y., Akay, C. Stem. Cells (2004)
- Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells. Gazitt, Y. Curr. Opin. Hematol. (2002)
- A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate. Gazitt, Y., Reddy, S.V., Alcantara, O., Yang, J., Boldt, D.H. J. Cell. Physiol. (2001)
- Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules. Gazitt, Y. J. Hematother. Stem Cell Res. (2001)
- Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphoma patients: a randomized prospective study. Gazitt, Y., Callander, N., Freytes, C.O., Shaughnessy, P., Liu, Q., Tsai, T.W., Devore, P. J. Hematother. Stem Cell Res. (2000)